Search

Copyright of Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi is the property of Journal of Clinical Hepatology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi is the property of Journal of Clinical Hepatology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi is the property of Journal of Clinical Hepatology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi is the property of Journal of Clinical Hepatology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi is the property of Journal of Clinical Hepatology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi is the property of Journal of Clinical Hepatology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi is the property of Journal of Clinical Hepatology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi is the property of Journal of Clinical Hepatology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Ｏｂｊｅｃｔｉｖｅ Ｔｏ ｉｎｖｅｓｔｉｇａｔｅ ｔｈｅ ｃｌｉｎｉｃａｌ ｅｆｆｅｃｔ ａｎｄ ｓａｆｅｔｙ ｏｆ ｔｒａｎｓａｒｔｅｒｉａｌ ｃｈｅｍｏｅｍｂｏｌｉｚａｔｉｏｎ （ＴＡＣＥ）ｗｉｔｈ ｕｌｔｒａ － ｌｉｑｕｉｄ ｉｏｄｉｚｅｄ ｏｉｌ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ｄｒｕｇ － ｅｌｕｔｉｎｇ ｂｅａｄｓ ｉｎ ｔｈｅ ｔｒｅａｔｍｅｎｔ ｏｆ Ｂａｒｃｅｌｏｎａ Ｃｌｉｎｉｃ Ｌｉｖｅｒ Ｃａｎｃｅｒ （ＢＣＬＣ）ｓｔａｇｅ Ｂ／ Ｃ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａ （ＨＣＣ）． Ｍｅｔｈｏｄｓ Ａ ｒｅｔｒｏｓｐｅｃｔｉｖｅ ａｎａｌｙｓｉｓ ｗａｓ ｐｅｒｆｏｒｍｅｄ ｆｏｒ ｔｈｅ ｃｌｉｎｉｃａｌ ｄａｔａ ｏｆ ５１ ｐａｔｉｅｎｔｓ ｗｉｔｈ ＢＣＬＣ ｓｔａｇｅ Ｂ／ Ｃ ＨＣＣ ｗｈｏ ｕｎｄｅｒｗｅｎｔ ＴＡＣＥ ｗｉｔｈ ｕｌｔｒａ － ｌｉｑｕｉｄ ｉｏｄｉｚｅｄ ｏｉｌ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ｄｒｕｇ － ｅｌｕｔｉｎｇ ｂｅａｄｓ ｉｎ Ｔｈｅ Ｆｉｒｓｔ Ａｆｆｉｌｉａｔｅｄ Ｈｏｓｐｉｔａｌ ｏｆ Ｓｏｏｃｈｏｗ Ｕｎｉｖｅｒｓｉｔｙ ｆｒｏｍ Ｍａｙ ２０１６ ｔｏ Ｓｅｐｔｅｍ ｂｅｒ ２０１８． Ｌｉｖｅｒ ｆｕｎｃｔｉｏｎ ｗａｓ ｏｂｓｅｒｖｅｄ ｂｅｆｏｒｅ ｔｒｅａｔｍｅｎｔ ａｎｄ ａｔ ３ ｄａｙｓ，７ ｄａｙｓ，ａｎｄ １ ｍｏｎｔｈ ａｆｔｅｒ ｔｒｅａｔｍｅｎｔ，ａｎｄ ａｄｖｅｒｓｅ ｅｖｅｎｔｓ ａｎｄ ｃｏｍｐｌｉ ｃａｔｉｏｎｓ ｗｅｒｅ ｒｅｃｏｒｄｅｄ ｉｎ ｄｅｔａｉｌ． Ｍｏｄｉｆｉｅｄ Ｒｅｓｐｏｎｓｅ Ｅｖａｌｕａｔｉｏｎ Ｃｒｉｔｅｒｉａ ｉｎ Ｓｏｌｉｄ Ｔｕｍｏｒｓ ｗａｓ ｕｓｅｄ ｔｏ ｅｖａｌｕａｔｅ ｃｌｉｎｉｃａｌ ｏｕｔｃｏｍｅ ａｔ １ ａｎｄ ３ ｍｏｎｔｈｓ ａｆｔｅｒ ｓｕｒｇｅｒｙ． Ｔｈｅ ｔ － ｔｅｓｔ ｗａｓ ｕｓｅｄ ｆｏｒ ｃｏｍｐａｒｉｓｏｎ ｏｆ ｃｏｎｔｉｎｕｏｕｓ ｄａｔａ ｂｅｔｗｅｅｎ ｔｗｏ ｇｒｏｕｐｓ． Ｒｅｓｕｌｔｓ Ｓｕｐｅｒｓｅｌｅｃｔｉｖｅ ＴＡＣＥ ｐｒｏｃｅｄｕｒｅ ｗａｓ ｃｏｍｐｌｅｔｅｄ ｉｎ ａｌｌ ５１ ｐａｔｉｅｎｔｓ． Ａｔ １ ｍｏｎｔｈ ａｆｔｅｒ ｓｕｒｇｅｒｙ，ｔｈｅ ｔａｒｇｅｔ ｌｅｓｉｏｎｓ ｈａｄ ａ ｄｉｓｅａｓｅ ｒｅｍｉｓｓｉｏｎ ｒａｔｅ ｏｆ ７０． ６％ ａｎｄ ａ ｄｉｓｅａｓｅ ｃｏｎｔｒｏｌ ｒａｔｅ ｏｆ ９６． １％ ，ｗｈｉｌｅ ａｔ ３ ｍｏｎｔｈｓ ａｆｔｅｒ ｓｕｒｇｅｒｙ，ｔｈｅ ｔａｒｇｅｔ ｌｅｓｉｏｎｓ ｈａｄ ａ ｄｉｓｅａｓｅ ｒｅｍｉｓｓｉｏｎ ｒａｔｅ ｏｆ ６４． ０％ ａｎｄ ａ ｄｉｓｅａｓｅ ｃｏｎｔｒｏｌ ｒａｔｅ ｏｆ ８８ ０％ ． Ｏｆ ａｌｌ ５１ ｐａｔｉｅｎｔｓ，５ （９． ８％ ）ｅｘｐｅｒｉｅｎｃｅｄ ａｃｕｔｅ ｌｉｖｅｒ ｉｎｊｕｒｙ ａｔ ３ ｄａｙｓ ａｆｔｅｒ ｓｕｒｇｅｒｙ，ａｎｄ ｔｈｅｒｅ ｗｅｒｅ ｓｉｇｎｉｆｉｃａｎｔ ｃｈａｎｇｅｓ ｉｎ ａｌａｎｉｎｅ ａｍｉｎｏｔｒａｎｓｆｅｒａｓｅ （ＡＬＴ），ａｓｐａｒｔａｔｅ ａｍｉｎｏｔｒａｎｓｆｅｒａｓｅ，ｔｏｔａｌ ｂｉｌｉｒｕｂｉｎ （ＴＢｉｌ），ａｎｄ ａｌｂｕｍｉｎ （Ａｌｂ）（ｔ ＝ － ５． ４５４，－ ３． ９９７，－ ５． ３４６，ａｎｄ ７ ２１２，ａｌｌ Ｐ ＜０． ００１）． Ｔｈｅｒｅ ｗｅｒｅ ａｌｓｏ ｓｉｇｎｉｆｉｃａｎｔ ｃｈａｎｇｅｓ ｉｎ ＡＬＴ，ＴＢｉｌ，ａｎｄ Ａｌｂ ａｔ ７ ｄａｙｓ ａｆｔｅｒ ｓｕｒｇｅｒｙ （ｔ ＝ － ３． １７７，－ ３． ６６５，ａｎｄ ３ １９４，ａｌｌ Ｐ ＜０． ０５）． Ｏｆ ａｌｌ ５１ ｐａｔｉｅｎｔｓ，３５ （６８． ６％ ）ｅｘｐｅｒｉｅｎｃｅｄ ｇｒａｄｅ １ ｏｒ ２ ａｄｖｅｒｓｅ ｅｖｅｎｔｓ ａｔ １ ｍｏｎｔｈ ａｆｔｅｒ ｓｕｒｇｅｒｙ，ａｎｄ ｎｏ ｃｏｍｐｌｉｃａ ｔｉｏｎｓ ｏｆ ｌｉｖｅｒ ｆａｉｌｕｒｅ，ｌｉｖｅｒ ａｂｓｃｅｓｓ，ｂｉｌｅ ｔｕｍｏｒ，ａｎｄ ｇａｓｔｒｏｉｎｔｅｓｔｉｎａｌ ｂｌｅｅｄｉｎｇ ｗｅｒｅ ｏｂｓｅｒｖｅｄ． Ｏｎｅ ｐａｔｉｅｎｔ ｄｉｅｄ ｏｆ ｍｕｌｔｉｐｌｅ ｏｒｇａｎ ｆａｉｌｕｒｅ ｄｕｅ ｔｏ ｔｕｍｏｒ ｐｒｏｇｒｅｓｓｉｏｎ ｏｎ ｄａｙ ６１ ａｆｔｅｒ ｓｕｒｇｅｒｙ． Ｃｏｎｃｌｕｓｉｏｎ ＴＡＣＥ ｗｉｔｈ ｕｌｔｒａ － ｌｉｑｕｉｄ ｉｏｄｉｚｅｄ ｏｉｌ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ｄｒｕｇ － ｅｌｕｔｉｎｇ ｂｅａｄｓ ｉｓ ｓａｆｅ ａｎｄ ｅｆｆｅｃｔｉｖｅ ｉｎ ｔｈｅ ｔｒｅａｔｍｅｎｔ ｏｆ ＢＣＬＣ ｓｔａｇｅ Ｂ／ Ｃ ＨＣＣ，ａｎｄ ｆｕｒｔｈｅｒ ｓｔｕｄｉｅｓ ａｒｅ ｎｅｅｄｅｄ ｔｏ ｏｂｓｅｒｖｅ ｌｏｎｇ － ｔｅｒｍ ｅｆｆｉｃａｃｙ ａｎｄ ｓｕｒｖｉｖａｌ ｂｅｎｅｆｉｔ． [ABSTRACT FROM AUTHOR]

Copyright of Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi is the property of Journal of Clinical Hepatology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Hepatocellular carcinoma (HCC) is a common malignant tumor in the world, and surgical resection and liver transplantation are two radical treatment modalities, but only 10% -20% of all patients can receive such treatments. In recent years, local therapies including radiofrequency ablation, microwave ablation, cryoablation, and the irreversible electroporation ablation which appeared recently have gradually become the alternative therapies for the patients who are unable to undergo surgery. In addition to local tumor growth control and im­provement in survival outcomes, the ablation technology also helps to downgrade tumor for secondary resection. This article focuses on the re­search progress in radiofrequency ablation alone and in combination with other therapies in the treatment of HCC, compares radiofrequency ablation with other local ablative therapies, and briefly introduces the application of intelligent navigation technology in adjuvant ablation. With the development of medical imaging and progress in related fields, the ablation technology will be widely applied in clinical practice in the future. [ABSTRACT FROM AUTHOR]